Artificial intelligence in dermatopathology: a systematic review
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llae361 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Roshni Mahesh Lalmalani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Singapore General Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Artificial Intelligence, Dermatology, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Medical research, driven by advancing technologies like artificial intelligence (AI), is transforming healthcare. Dermatology, known for its visual nature, benefits from AI, especially in dermatopathology with digitized slides. This review explores AI’s role, challenges, opportunities and future potential in enhancing dermatopathological diagnosis and care. Adhering to PRISMA and Cochrane Handbook standards, this systematic review explored AI’s function in dermatopathology. It employed an interdisciplinary method, encompassing diverse study types and comprehensive database searches. Inclusion criteria encompassed peer-reviewed articles from 2000 to 2023, with a focus on practical AI use in dermatopathology. Numerous studies have investigated AI’s potential in dermatopathology. We reviewed 112 papers. Notable applications include AI classifying histopathological images of naevi and melanomas, although challenges exist regarding subtype differentiation and generalizability. AI achieved high accuracy in melanoma recognition from formalin-fixed paraffin-embedded samples but faced limitations due to small datasets. Deep learning algorithms showed diagnostic accuracy for specific skin conditions, but challenges persisted, such as small sample sizes and the need for prospective validation. This systematic review underscores AI’s potential in enhancing dermatopathology for better diagnosis and patient care. Addressing challenges like limited datasets and potential biases is essential. Future directions involve expanding datasets, conducting validation studies, promoting interdisciplinary collaboration, and creating patient-centred AI tools in dermatopathology to enhance accuracy, accessibility and patient-focused care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Singapore General Hospital, Singapore, Singapore.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Duke-NUS Medical School, Singhealth, Singapore, Singapore.
Zitieren
APA
Lalmalani, R. M., Lim, C. X. Y., & Oh, C. C. (2025). Artificial intelligence in dermatopathology: a systematic review. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae361
Vancouver
Lalmalani RM, Lim CXY, Oh CC. Artificial intelligence in dermatopathology: a systematic review. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llae361
BibTeX
@article{Lalmalani2025,
author = {Lalmalani, Roshni Mahesh and Lim, Clarissa Xin Yu and Oh, Choon Chiat},
title = {Artificial intelligence in dermatopathology: a systematic review},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llae361}
}
EUVIMED